EUVIMEDEUVIMED entdecken
Open Access

Clinical Phenogroup Diversity and Multiplicity: Impact on Mechanisms of Exercise Intolerance in Heart Failure with Preserved Ejection Fraction

Kathryn Larson, Massar Omar, Hidemi Sorimachi, Kazunori Omote, Alessio Alogna, Dejana Popovic, Atsushi Tada, Shunichi Doi, Jwan Naser, Yogesh N V Reddy, Margaret M Redfield, Barry A Borlaug

European Journal of Heart Failure · 2024

DOI: 10.1002/ejhf.3105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, 2024. Verfasst von Kathryn Larson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Heart Failure, Exercise Tolerance, Stroke Volume, Exercise Test. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

We aimed to clarify the extent to which cardiac and peripheral impairments to oxygen delivery and utilization contribute to exercise intolerance and risk for adverse events, and how this relates to diversity and multiplicity in pathophysiologic traits. Methods and results Individuals with heart failure with preserved ejection fraction (HFpEF) and non-cardiac dyspnoea (controls) underwent invasive cardiopulmonary exercise testing and clinical follow-up. Haemodynamics and oxygen transport responses were compared. HFpEF patients were then categorized a priori into previously-proposed, non-exclusive descriptive clinical trait phenogroups, including cardiometabolic, pulmonary vascular disease, left atrial myopathy, and vascular stiffening phenogroups based on clinical and haemodynamic profiles to contrast pathophysiology and clinical risk. Overall, patients with HFpEF (n = 643) had impaired cardiac output reserve with exercise (2.3 vs. 2.8 L/min, p = 0.025) and greater reliance on peripheral oxygen extraction augmentation (4.5 vs. 3.8 ml/dl, p < 0.001) compared to dyspnoeic controls (n = 219). Most (94%) patients with HFpEF met criteria for at least one clinical phenogroup, and 67% fulfilled criteria for multiple overlapping phenogroups. There was greater impairment in peripheral limitations in the cardiometabolic group and greater cardiac output limitations and higher pulmonary vascular resistance during exertion in the other phenogroups. Increasing trait multiplicity within a given patient was associated with worse exercise haemodynamics, poorer exercise capacity, lower cardiac output reserve, and greater risk for heart failure hospitalization or death (hazard ratio 1.74, 95% confidence interval 1.08–2.79 for 0–1 vs. ≥2 phenogroup traits present).

Conclusions

Though cardiac output response to exercise is limited in patients with HFpEF compared to those with non-cardiac dyspnoea, the relative contributions of cardiac and peripheral limitations vary with differing numbers and types of clinical phenotypic traits present. Patients fulfilling criteria for greater multiplicity and diversity of HFpEF phenogroup traits have poorer exercise capacity, worsening haemodynamic perturbations, and greater risk for adverse outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureExercise ToleranceStroke VolumeExercise TestHumansFemaleMaleAgedMiddle AgedOxygen ConsumptionPhenotypeDyspneaHemodynamics

Stichwörter der Autor:innen

Exercise capacityHFpEFHeart failureOutcomePhenotype

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
  • Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Steno Diabetes Center, Odense University Hospital, Odense, Denmark.
  • Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Deutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Campus Virchow-Klinikum, Berlin, Germany.
  • DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • NCATS NIH HHS
  • US Department of Defense
  • NIH
  • National Center for Advancing Translational Sciences

Zitieren

APA

Larson, K., Omar, M., Sorimachi, H., Omote, K., Alogna, A., Popovic, D., Tada, A., Doi, S., Naser, J., Reddy, Y. N. V., Redfield, M. M., & Borlaug, B. A. (2024). Clinical Phenogroup Diversity and Multiplicity: Impact on Mechanisms of Exercise Intolerance in Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3105

Vancouver

Larson K, Omar M, Sorimachi H, Omote K, Alogna A, Popovic D, et al. Clinical Phenogroup Diversity and Multiplicity: Impact on Mechanisms of Exercise Intolerance in Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. 2024. doi:10.1002/ejhf.3105

BibTeX
@article{Larson2024,
  author = {Larson, Kathryn and Omar, Massar and Sorimachi, Hidemi and Omote, Kazunori and Alogna, Alessio and Popovic, Dejana and Tada, Atsushi and Doi, Shunichi and Naser, Jwan and Reddy, Yogesh N V and Redfield, Margaret M and Borlaug, Barry A},
  title = {Clinical Phenogroup Diversity and Multiplicity: Impact on Mechanisms of Exercise Intolerance in Heart Failure with Preserved Ejection Fraction},
  journal = {European Journal of Heart Failure},
  year = {2024},
  doi = {10.1002/ejhf.3105}
}
Kostenlos starten →